Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial

Komal Jhaveri, Patrick Neven, M.L. Casalnuovo, Sung‐Bae Kim, E. Tokunaga, P. Aftimos, Cristina Saura, J O'Shaughnessy, N. Harbeck, Lisa A. Carey, Giuseppe Curigliano, Junichiro Watanabe, Elgene Lim, Junpeng Huang, Z. Qingyuan, Antonio Llombart‐Cussac, Chiun‐Sheng Huang, B. Desai, Y. Limay, X.A. Wang, Shengnan Cao, François‐Clément Bidard